Download PDF
Dtsch Med Wochenschr 2012; 137(34/35): 1701-1704
DOI: 10.1055/s-0032-1305243
Aktuelle Diagnostik & Therapie | Review article
Pharmakologie
© Georg Thieme Verlag KG Stuttgart · New York

Perioperatives Medikamentenmanagement

Perioperative medication management
B. Gschiel
1   Abteilung für Anästhesie und Intensivmedizin Klinikum Klagenfurt am Wörthersee, Österreich
,
G. Fritsch
2   Anästhesie, perioperative Medizin und allgemeine Intensivmedizin der Paracelsus Medizinischen Universität Salzburg, Österreich
,
M. Bock
3   1. Dienst für Anästhesie und Intensivmedizin, Zentralkrankenhaus Bozen, Italien; affiliiert zur Paracelsus Medizinischen Universität Salzburg, Österreich
› Author Affiliations
Further Information

Publication History

27 April 2012

30 May 2012

Publication Date:
14 August 2012 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Das perioperative Management der Dauermedikation von Patienten, die sich chirurgischen Eingriffen unterziehen müssen, erfordert ein rechtzeitiges und interdisziplinäres Zusammenspiel der einzelnen medizinischen Fachdisziplinen. Patienten mit einer höhergradigen ASA- Klassifikation (Evaluierung nach der Klassifikation der American Society of Anesthesiologists) sind häufig multimorbide Patienten, die an einer Vielzahl internistischer Erkrankungen leiden und eine große Anzahl an Medikamenten zur Therapie dieser Erkrankungen einnehmen. Mit einer steigenden Anzahl dieser Substanzen kommt es auch zu häufiger auftretenden Arzneimittelinteraktionen.

In der perioperativen Phase kommen noch Wechselwirkungen mit inhalativen und intravenösen Anästhetika sowie spezifische Blutungskomplikationen hinzu, die bereits präoperativ berücksichtigt werden müssen.

Die vorliegende Arbeit hat das Ziel, das perioperative Management der internistischen Begleittherapie bei nichtkardiochirurgischen Patienten an Hand der aktuellen Evidenz zusammenzufassen. Besonders auf dem Gebiet der kardiovaskulären Medikation sind in den letzten Jahren Evidenz basierte Empfehlungen publiziert worden, hier vor allem im Bereich der Beta-Blocker Therapie. Für andere Substanzgruppen bestehen die Empfehlungen weiterhin häufig aus Expertenmeinungen, pharmakologischen Empfehlungen, Arzneimittelinteraktionen oder Fallberichten, da nur wenige randomisiert kontrollierte Studien zur Verfügung stehen. Die vorliegenden epidemiologischen Studien sind heterogen.

Abstract

The management of chronic medication in the perioperative phase represents as a serious challenge for the involved physicians. Especially patients with elevated ASA-scores frequently suffer from multiple co-morbidities which often need numerous medications. The probability of pharmacological interactions rises with the number of these medications. Moreover it must be taken into consideration that chronic medication potentially interferes with both intravenous and inhaled anesthetics and moreover, bleeding complications are more likely to occur in patients undergoing chronic pharmacotherapy.

The aim of this article is to provide a summary of the existing evidence concerning perioperative medication in patients undergoing non-cardiac surgery. Several guidelines and advisories dealing with cardiovascular medication have been published during the last decade. The main scope of these publications was on beta-blockers and other cardiovascular medication. There is less evidence on not-cardiovascular medication as in most cases only case reports and expert opinions are published. Existing epidemiologic studies on this topic are rather heterogeneous.

Schlüsselwörter

perioperative Medikation - Chirurgie - Dauertherapie - Risikomanagement - Patientensicherheit

Keywords

perioperative medication - surgery - chronic medication - risk management - patient safety
 

  • Literatur

  • 1 Andrade C, Sandarsh S, Chethan KB et al. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010; 71: 1565-1575
    CrossrefPubMedGoogle Scholar
  • 2 Auerbach AD, Goldman L. beta-Blockers and reduction of cardiac events in noncardiac surgery: clinical applications. JAMA 2002; 287: 1445-1447
    CrossrefPubMedGoogle Scholar
  • 3 Ballwieser DA, Chappell D, Jacob M. Insulinresistenz: Bedeutung in der Anästhesie und Intensivmedizin – Perioperative Stoffwechselkontrolle bei Diabetikern und Nichtdiabetikern. Anasthesiol Intensivmed Notfallmed Schmerzther 2011; 46: 258-266; quiz 267
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Barnett SR. Polypharmacy and perioperative medications in the elderly. Anesthesiology clinics 2009; 27: 377-389
    CrossrefPubMedGoogle Scholar
  • 5 Biccard BM, Sear JW, Foex P. Acute peri-operative beta blockade in intermediate-risk patients. Anaesthesia 2006; 61: 924-931
    CrossrefPubMedGoogle Scholar
  • 6 Bock M, Wiedermann CJ, Motsch J et al. Minimizing cardiac risk in perioperative practice – interdisciplinary pharmacological approaches. Wien Klin Wochenschr 2011; 123: 393-407
    CrossrefPubMedGoogle Scholar
  • 7 Buhre K, de Rossi L, Buhre W. Präoperative Dauertherapie. Anaesthesist 2005; 54: 902-913
    CrossrefPubMedGoogle Scholar
  • 8 Buse GL, Bucher E, Seeberger MD et al. Chronische Medikation im Vorfeld operativer Eingriffe: absetzen – beibehalen – ausbauen?. Ther Umschau 2009; 66: 509-517
    PubMedGoogle Scholar
  • 9 Castanheira L, Fresco P, Macedo AF. Guidelines for the management of chronic medication in the perioperative period: systematic review and formal consensus. J Clin Pharm Ther 2011; 36: 446-467
    CrossrefPubMedGoogle Scholar
  • 10 Copeland LA, Zeber JE, Pugh MJ et al. Postoperative complications in the seriously mentally ill: a systematic review of the literature. Ann Surg 2008; 248: 31-38
    CrossrefPubMedGoogle Scholar
  • 11 Cornia PB, Anawalt BD. Rational use of perioperative corticoid supplementation in patients at risk for acute adrenal insufficiency. Hosp Physician 2003; 48: 39-44
    PubMedGoogle Scholar
  • 12 Devereaux PJ, Goldman L, Cook DJ et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 2005; 173: 627-634
    CrossrefPubMedGoogle Scholar
  • 13 Devereaux PJ, Yang H, Yusuf S et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371: 1839-1847
    CrossrefPubMedGoogle Scholar
  • 14 Duncan AE, Abd-Elsayed A, Maheshwari A et al. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology 2010; 112: 860-871
    CrossrefPubMedGoogle Scholar
  • 15 Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116: e418-499
    CrossrefPubMedGoogle Scholar
  • 16 Fleisher LA, Beckman JA, Brown KA et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009; 120: e169-276
    CrossrefPubMedGoogle Scholar
  • 17 Fraser CG, Preuss FS, Bigford WD. Adrenal atrophy and irreversible shock associated with cortisone therapy. JAMA 1952; 149: 1542-1543
    CrossrefPubMedGoogle Scholar
  • 18 Girard M, Schricker T. Perioperative glucose control: living in uncertain times--Continuing Professional Development. Can J Anaesth 2011; 58: 312-320, 320-319
    PubMedGoogle Scholar
  • 19 Hindler K, Shaw AD, Samuels J et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006; 105: 1260-1272; quiz 1289-1290
    CrossrefPubMedGoogle Scholar
  • 20 Kalenka A, Hinkelbein J. Anästhesie bei Patienten mit Parkinson-Erkrankung. Anaesthesist 2005; 54: 401-409
    CrossrefPubMedGoogle Scholar
  • 21 Kheterpal S, Khodaparast O, Shanks A et al. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J cardiothorac vasc Anesth 2008; 22: 180-186
    CrossrefPubMedGoogle Scholar
  • 22 King Jr JT, Goulet JL, Perkal MF et al. Glycemic control and infections in patients with diabetes undergoing noncardiac surgery. Ann Surg 2011; 253: 158-165
    CrossrefPubMedGoogle Scholar
  • 23 Lewis L, Robinson RF, Yee J et al. Fatal adrenal cortical insufficiency precipitated by surgery during prolonged continuous cortisone treatment. Ann Intern Med 1953; 39: 116-126
    CrossrefPubMedGoogle Scholar
  • 24 Marks JB. Perioperative management of diabetes. Am Fam Physician 2003; 67: 93-100
    PubMedGoogle Scholar
  • 25 Maynard G, O’Malley CW, Kirsh SR. Perioperative care of the geriatric patient with diabetes or hyperglycemia. Clin Geriatr Med 2008; 24: 649-665, viii
    CrossrefPubMedGoogle Scholar
  • 26 Mercado DL, Petty BG. Perioperative medication management. Med Clin North Am 2003; 87: 41-57
    CrossrefPubMedGoogle Scholar
  • 27 Moghissi ES, Korytkowski MT, DiNardo M et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes care 2009; 32: 1119-1131
    CrossrefPubMedGoogle Scholar
  • 28 Nicholson G, Burrin JM, Hall GM. Peri-operative steroid supplementation. Anaesthesia 1998; 53: 1091-1104
    CrossrefPubMedGoogle Scholar
  • 29 Olsen MA, Nepple JJ, Riew KD et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Jount Surg Am 2008; 90: 62-69
    PubMedGoogle Scholar
  • 30 Poldermans D, Bax JJ, Boersma E et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009; 30: 2769-2812
    CrossrefPubMedGoogle Scholar
  • 31 Redel A, Schwemmer U. Perioperative Modifikation der Dauermedikation bei kardiovaskulären, pulmonalen und metabolischen Erkrankungen. Anasthesiol Intensivmed Notfallmed Schmerzther 2008; 43: 144-154
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Rivera R, Antognini JF. Perioperative drug therapy in elderly patients. Anesthesiology 2009; 110: 1176-1181
    CrossrefPubMedGoogle Scholar
  • 33 Robertshaw HJ, Hall GM. Diabetes mellitus: anaesthetic management. Anaesthesia 2006; 61: 1187-1190
    CrossrefPubMedGoogle Scholar
  • 34 Roth A, Angster R, Forst H. Begleitmedikation – Notwendigkeit, Nebenwirkungen und Interaktionen in der perioperativen Phase. Anaesthesist 1999; 48: 267-283
    CrossrefPubMedGoogle Scholar
  • 35 Roth A, Angster R, Forst H. Begleitmedikation – Notwendigkeit, Nebenwirkungen und Interaktionen in der perioperativen Phase. Anaesthesist 1999; 48: 267-283
    CrossrefPubMedGoogle Scholar
  • 36 Saber W. Perioperative medication management: a case-based review of general principles. Cleve Clin J Med 2006; 73 (Suppl. 01) 82-87
    CrossrefPubMedGoogle Scholar
  • 37 Schiavi A, Papangelou A, Mirski M. Preoperative preparation of the surgical patient with neurologic disease. Med Clin North Am 2009; 93: 1123-1130
    CrossrefPubMedGoogle Scholar
  • 38 Schirmer U, Schurmann W. Zur perioperativen Gabe von ACE-Hemmern. Anaesthesist 2007; 56: 557-561
    CrossrefPubMedGoogle Scholar
  • 39 Smith I, Jackson I. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?. Curr Opin Anaesthesiol 2010; 23: 687-690
    CrossrefPubMedGoogle Scholar
  • 40 Tuttnauer A, Levin PD. Diabetes mellitus and anesthesia. Anesthesiology clinics 2006; 24: 579-597
    PubMedGoogle Scholar
  • 41 Vogel Kahmann I, Ruppen W, Lurati Buse G et al. Langzeitmedikation und perioperatives Management. Internist 2011; 52: 89-98
    CrossrefPubMedGoogle Scholar
  • 42 Wallace AW, Au S, Cason BA. Association of the pattern of use of perioperative beta-blockade and postoperative mortality. Anesthesiology 2010; 113: 794-805
    CrossrefPubMedGoogle Scholar
  • 43 Wappler FTP, Bürkle H. Anästhesie und Begleiterkrankungen – Perioperatives Management des kranken Patienten. Thieme Verlag; 2006
    Google Scholar
  • 44 Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg 2003; 97: 634-641
    PubMedGoogle Scholar
  • 45 Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003; 114: 742-752
    CrossrefPubMedGoogle Scholar
  • 46 Wullner U, Kassubek J, Odin P et al. Transdermal rotigotine for the perioperative management of Parkinson's disease. J Neural Transm 2010; 117: 855-859
    CrossrefPubMedGoogle Scholar